Search
Search Results
##search.searchResults.foundPlural##
-
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3746PDF: 1469HTML: 188 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3581PDF: 2510HTML: 1497 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
806PDF: 96HTML: 146 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4376PDF: 1723HTML: 1043 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3067PDF: 918HTML: 2042 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2600PDF: 879HTML: 2125 -
-
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4092PDF: 1159HTML: 1962Fig.1: 219Fig. 2: 113Table 1: 204Table2: 225Table 3: 203 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1349HTML: 328PDF: 958Suppl. Files: 469 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3264PDF: 1462HTML: 5953Fig1-Ag-Pil: 234Ag-Pil Fig.2: 237 -
-
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2921PDF: 1374HTML: 3578Untitled: 196Untitled: 211Untitled: 184 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3257PDF: 1024HTML: 2033 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2169PDF: 1721HTML: 383 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3223PDF: 786HTML: 2972Figure 1a and 1b: 153Figure 2: 163Figure 3: 181Figure 4: 164Figure 5: 167Tables 1-5: 156 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3333PDF: 1251HTML: 2209 -
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1187PDF: 542HTML: 213 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3791PDF: 1601HTML: 500Figures . Eliassian: 229 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4355PDF: 1522HTML: 1555Untitled: 239 -
Simultaneous dual pathology in lymph node
1668PDF: 703HTML: 7721Simultaneous dual pathology in lymph node: 177Simultaneous dual pathology in lymph node: 178Simultaneous dual pathology in lymph node: 153Simultaneous dual pathology in lymph node: 191Simultaneous dual pathology in lymph node: 179 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1890PDF: 785HTML: 528 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2561PDF: 853HTML: 8899Efremov 1: 236Efremov 2: 201 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2636PDF: 1631HTML: 2373Table1: 195 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1292PDF: 477HTML: 18612Figure 1: 174Figure 2: 154Figure 3: 171Figure 4: 210Figure 5: 182 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1302PDF: 502HTML: 206 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2060PDF: 846HTML: 259 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1628PDF: 891HTML: 3159Figure 5: 158Figure 4: 159Figure 3: 194Figure 1: 174Figure 2: 170
1 - 43 of 43 items







